Antibiotics
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-02033 |
Pluracidomycin B (82138-65-6) Inquiry |
|
Pluracidomycin B is a carbapenem antibiotic produced by Str. pluracidomyceticus nov. sp. It has anti-gram-positive bacteria and gram-negative bacteria activity, and has the effect of inhibiting β-lactamase. |
||
BBF-02034 |
Pluracidomycin C1 (82138-66-7) Inquiry |
|
Pluracidomycin C1 is a carbapenem antibiotic produced by Str. pluracidomyceticus nov. sp. It has anti-gram-positive bacteria and gram-negative bacteria activity, and has the effect of inhibiting β-lactamase. |
||
BBF-02035 | ||
Pluraflavin A is an antitumor antibiotic produced by Saccharothrix sp. DSM 12931. Pluraflavin A has the effect of inhibiting the transcription of glucose-6-phosphatase gene and has good anti-proliferation activity on tumor cells. |
||
BBF-02036 | ||
Pluraflavin C is an antitumor antibiotic produced by Saccharothrix sp. DSM 12931. It has good anti-proliferation activity on tumor cells. |
||
BBF-02037 | ||
Pluraflavin E is an antitumor antibiotic produced by Saccharothrix sp. DSM 12931. It has good anti-proliferation activity on tumor cells. |
||
BBF-02038 | ||
Pneumocandin A4 is a lipopeptide antibiotic produced by Zalerion arboricola. It has a strong anti-Candida effect. It has the effect of inhibiting the synthesis of 1,3 early-glucan in vitro, with an IC50 of 0.07-0.5 μg/mL. |
||
BBF-02039 | ||
Pneumocandin B2 is a lipopeptide antibiotic produced by Zalerion arboricola. It has a strong anti-Candida effect. It has the effect of inhibiting the synthesis of 1,3 early-glucan in vitro, with an IC50 of 0.07-0.5 μg/mL. |
||
BBF-02040 |
Polymyxin B2 (34503-87-2) Inquiry |
|
Polymyxin B2 is a cyclic peptide antibiotic of Bacillus polymyxa. The effect of anti-gram-negative bacteria is greater than that of anti-gram-positive bacteria. |
||
BBF-02041 |
Polymyxin D1 (10072-50-1) Inquiry |
|
Polymyxin D1 is a cyclic peptide antibiotic of Bacillus polymyxa. The effect of anti-gram-negative bacteria is greater than that of anti-gram-positive bacteria. |
||
BBF-02042 |
Polymyxin D2 (34167-45-8) Inquiry |
|
Polymyxin D2 is a cyclic peptide antibiotic of Bacillus polymyxa. The effect of anti-gram-negative bacteria is greater than that of anti-gram-positive bacteria. |
||
BBF-02043 |
Polymyxin S1 (63700-38-9) Inquiry |
|
Polymyxin S1 is a cyclic peptide antibiotic of Bacillus polymyxa RS-6. Activity against gram-positive bacteria. |
||
BBF-02044 |
Polymyxin T1 (63700-39-0) Inquiry |
|
Polymyxin T1 is a cyclic peptide antibiotic of Bacillus polymyxa E-12. The effect of anti-gram-negative bacteria is greater than that of anti-gram-positive bacteria. |
||
BBF-02045 |
Polyoxin C (21027-33-8) Inquiry |
|
Polyoxin C is a nucleoside antifungal antibiotic produced by Str. cacaor var. asoensis and Str. piomogenus. |
||
BBF-02046 |
Polyoxin N (37362-29-1) Inquiry |
|
Polyoxin is a nucleoside antifungal antibiotic produced by Str. cacaor var. asoensis and Str. piomogenus. |
||
BBF-02048 |
Polyporenic acid A (516-25-6) Inquiry |
|
Polyporenic acid A is a steroid antibiotic produced by Polyporus betulinus and Polyporus benzoinus. |
||
BBF-02049 |
Porothramycin A (110652-73-8) Inquiry |
|
Porothramycin A is an antibiotic produced by Str.albus K731-113. It has activity against gram-positive bacteria and anaerobic bacteria. |
||
BBF-02050 |
Porothramycin B (110652-72-7) Inquiry |
|
Porothramycin B is an antibiotic produced by Str.albus K731-113. It has activity against gram-positive bacteria and anaerobic bacteria. |
||
BBF-02052 |
Pradimicin A (117704-65-1) Inquiry |
|
Pradimicin A is an antibiotic produced by Actinomadura hibisca. It has strong antifungal and yeast activity. |
||
BBF-02053 |
Pradimicin B (117704-66-2) Inquiry |
|
Pradimicin B is an antibiotic produced by Actinomadura hibisca. It has strong antifungal and yeast activity. |
||
BBF-02054 |
Pradimicin Q (141869-53-6) Inquiry |
|
Pradimicin Q is an antibiotic produced by Actinomadura verrucosospora subsp. neohibisca R 103-3. The cytotoxicity (IC50) to human colon HCT-116 cells and murine melanoma B16-F10 cells are 75 and 100 μg/mL, respectively. |